Transverse Versus Longitudinal Groin Incision in Vascular Surgery
Launched by KOLDING SYGEHUS · Oct 7, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the best way to make incisions in the groin area during vascular surgery for patients with conditions like Peripheral Arterial Disease (PAD) or aneurysms. Researchers want to find out if a transverse (horizontal) incision leads to fewer problems, such as infections or complications, compared to a longitudinal (vertical) incision. They will also see if the type of incision affects how long patients stay in the hospital, whether they need to return for more surgery, or if there are fewer cases of amputation.
To be eligible for this trial, participants need to be having vascular surgery that requires an incision in the groin. However, those who have had previous groin surgeries, are having emergency procedures, or need specific muscle repairs will not be included. If you join the trial, you will be randomly assigned to one of the two incision types. The study is not yet recruiting participants, but it aims to provide important information on the best surgical practices for groin surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patients undergoing vascular reconstruction with a groin incision
- Exclusion Criteria:
- • Patients previously operated with a groin incision.
- • Patients undergoing operation due to trauma, bleeding, or pseudoaneurysm.
- • Patients operated within the first 24 hours of admission.
- • If it prior to the operation is deemed necessary with a muscleplasty.
About Kolding Sygehus
Kolding Sygehus is a leading healthcare institution in Denmark, dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong commitment to scientific excellence and ethical standards, Kolding Sygehus collaborates with multidisciplinary teams to conduct rigorous studies across various therapeutic areas. The hospital's state-of-the-art facilities and experienced research staff enable the exploration of new treatments and interventions, contributing to the development of evidence-based practices in healthcare. By fostering partnerships with academic institutions and industry stakeholders, Kolding Sygehus plays a pivotal role in enhancing clinical outcomes and promoting health advancements both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kolding, , Denmark
Patients applied
Trial Officials
Kim Trine Maria Mejnert Jørgensen, MD, PhD
Study Director
Department of vascular surgery, Kolding Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported